IU Health transplant chief quits, citing rift

The top transplant surgeon at Indiana University Health, who built the program into one of the nation’s largest, has resigned, citing growing differences with hospital administration.

Dr. Joseph Tector left IU Health on March 31 and has taken a position as professor of surgery at the University of Alabama School of Medicine.

Joseph Tector Tector

He will also head the university’s xenotransplantation program, which focuses on transplanting animal organs, tissues and cells into human recipients. On April 8, that program was awarded a five-year, $19.5 million grant from United Therapeutics Corp. with the goal of developing genetically modified kidney transplants from pig models to humans by 2021.

Tector said he decided to leave after concluding the institution had changed its focus “from one of pre-eminence to one of control and profit.”

“IU Health now looks for physicians who are willing to function as robots responsible for generating revenue for the institution, not as caregivers,” he said in a statement.

Organ transplantations are big business. A hospital bill for a liver transplant can cost more than $700,000, and a heart transplant can cost $1.2 million, according to a 2014 report by Milliman Research.

Dr. Gary Dunnington, chairman of surgery at the Indiana University School of Medicine, said in a statement that Tector provided “15 years of remarkable leadership of the abdominal transplant program, taking it to national prominence for both volume and quality.”

Dunnington added that Dr. Jonathan Fridell, who is serving as interim chief of abdominal transplant in the wake of Tector’s departure, is providing strong leadership and that transplant volumes in the first quarter are exceeding projections.

Tector joined IU Health in 2001 as a liver transplant surgeon and was appointed chief of transplantation at the IU School of Medicine in 2004. Three years later, he helped form the IU Health Transplant Institute and became its chief medical officer.

Under his leadership, the program became one of the five largest in the country. Last year, IU’s transplant surgeons performed 457 transplants of the kidney, heart, lung, pancreas, intestine and other organs.

It is one of only three medical institutions in Indiana to perform organ transplants, along with St. Vincent Hospital in Indianapolis and Lutheran Hospital in Fort Wayne.

In an interview, Tector said he was told in a letter from Dennis Murphy, president of IU Health, that the transplant institute would cease some of its research functions this year. No reason was given, he said.

He said he feared that would end his ability to do research in a highly specialized field focused on ways to transplant nonhuman animal cells and organs into humans.

Currently, 10 patients die each day in the United States while on the waiting list to receive vital-organ transplants, according to the U.S. Food and Drug Administration. “Recent evidence has suggested that transplantation of cells and tissues may be therapeutic for certain diseases such as neurodegenerative disorders and diabetes, where, again human materials are not usually available,” according to the FDA website.

Tector said xenotransplantation became his life pursuit in 1984 after the case of Baby Fae, who received a baboon heart for treatment of hypoplastic left heart syndrome.

Pig heart valves have been used for years, and some scientists believe whole organ transplants from genetically modified pigs are possible soon if immunological and physiological barriers can be overcome, according to University of Alabama researchers.

Tector said he was happy to join IU Health and the medical school 15 years ago, when the institutions provided him a chance to further the research.

But in recent years, IU Health has “made aggressive moves to hinder the research program,” he said, such as closing a farm where new pigs were created without giving him any warning.

He said the institution has slashed expenses by cutting experienced staff and increasing revenue through raising charges for organs 78 percent since 2010.

Tector’s attorney, Bill Broydrick, said the departure has been a messy one, and his client is trying to get back wages and penalties worth $4.7 million, along with the rights to take some laboratory equipment and cell lines to Alabama.

Whitney Ertel, IU Health director of public relations, said the hospital system does not owe Tector any money and does not have a contract with him. She said his contract is with his physician group and the IU Health Transplant Institute.•

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.